Business Economy


Sensex down by 113.65 points

Sensex down by 113.65 points

Mumbai, June 6 (UNI) The BSE Sensex on Friday fell by 113.65 pts to 81,328.39 in early trade tracking negative cues from Asian peers.

The Nifty eased by 20.60 pts at 24,748.70.

Sensex registered an intra-day high and a low at 81,464.59 and 81,318,28 respectively.

The Nifty registered the day's high at 24,763.35 and low at 24,728.20 pts.

Sectoral loser were Financial by 0.21 pc, healthcare by 0.23, IT by 0,36 , telcom by 0.37 pc, industrial by 0.08 pc, capital goods by 0.24 pc and Bankex by 0.21 pc.

Sectoral gainer were realty by 0.92 pc, power by 0,45, oil & gas by 0.43 pc, metal by 0.22 pc, energy by 0.27 pc and FMCG by 0.25pc

The Mid cap fell by 27.25 points and Small cap advanced by 65.21 point.

The losers were Tata Motors by 0.50 pc to Rs 706.55, ICICI Bank by 0.43 pc to Rs 1,448.50, Bajaj Finance by 0.42 pc to Rs 8,894.65, Bajaj Finserv by 0.38 pc to Rs 0.38 pc and Reliance by 0.33 pc to 14,539.30.

The gainer were Tata steel by 1.26 pc to Rs 156.25, Indusbank by 1.12 pc to Rs 812.10, Eternal by 0.55 pc to RS 2,567.95, NTPC by 0.49 pc to Rs 330.25 and Power Grid by 0.22pc to Rs 294.90.

UNI JS PRS

More News

ZEE5 unveils new brand identity

07 Jun 2025 | 9:14 PM

Mumbai, Jun 7 (UNI) ZEE5 on Saturday announced a bold new brand identity and strategic shift, reaffirming its positioning as India’s foremost homegrown platform.

see more..

Atria Renewabic launches rooftop solar campaign

07 Jun 2025 | 8:25 PM

Bengaluru, June 7 (UNI) Atria Renewabic, a frontrunner in India's renewable energy sector, on Saturday launched a unique community-centric rooftop solar campaign aimed at accelerating solar adoption in Bengaluru’s residential neighbourhoods.

see more..

Lupin gets tentative approval from U S FDA for Oxcarbazepine ER Tablets

07 Jun 2025 | 8:16 PM

Hyderabad, June 7 (UNI) Global pharma major Lupin Limited (Lupin) announced on Saturday that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Oxcarbazepine Extended-Release (ER) Tablets, 150 mg, 300 mg, and 600 mg.
This product would be manufactured at Lupin’s Nagpur facility in India, the Pharma company said in
a release.

see more..

G Square Group announces mega township project in Coimbatore

07 Jun 2025 | 8:14 PM

Hyderabad, June 7 (UNI) G Square Group, a leading South Indian real estate developer, on
Saturday announced G Square Seven Hills, an expansive township project in Coimbatore.

see more..

Aditya Birla Jewellery opens its outlet in Patna

07 Jun 2025 | 7:27 PM

Patna, June 07 (UNI) Indriya, the jewellery brand from the Aditya Birla Group, has launched its second outlet in Patna, reflecting the city’s growing appreciation for craftsmanship and exquisite design.

see more..